608
Views
31
CrossRef citations to date
0
Altmetric
Lasers/Surgery

Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency

, , &
Pages 352-356 | Received 26 Jul 2018, Accepted 23 Aug 2018, Published online: 28 Sep 2018

References

  • Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65:689–697. quiz 98.
  • Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65:699–714.
  • Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28:648–660.
  • Torres-Alvarez B, Mesa-Garza IG, Castanedo-Cazares JP, et al. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane. Am J Dermatopathol. 2011;33:291–295.
  • Park TJ, Kim M, Kim H, et al. Wnt inhibitory factor (WIF)-1 promotes melanogenesis in normal human melanocytes. Pigment Cell Melanoma Res. 2014;27:72–81.
  • Mansouri P, Farshi S, Hashemi Z, et al. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol. 2015;173:209–217.
  • Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75:385–392.
  • Hofbauer Parra CA, Careta MF, Valente NY, et al. Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatologic Surg. 2016;42:507–512.
  • Gokalp H, Akkaya AD, Oram Y. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: is it effective? J Cosmetic Dermatol. 2016;15:420–426.
  • Lee MC, Chang CS, Huang YL, et al. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lasers Med Sci. 2015;30:159–163.
  • Alexiades-Armenakas M, Rosenberg D, Renton B, et al. Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity. Arch Dermatol. 2010;146:396–405.
  • Vejjabhinanta V, Wanitphakdeedecha R, Limtanyakul P, et al. The efficacy in treatment of facial atrophic acne scars in Asians with a fractional radiofrequency microneedle system. J Eur Acad Dermatol Venereol. 2014;28:1219–1225.
  • Fitzpatrick R, Geronemus R, Goldberg D, et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med. 2003;33:232–242.
  • Zheng Z, Goo B, Kim DY, et al. Histometric analysis of skin-radiofrequency interaction using a fractionated microneedle delivery system. Dermatologic Surg. 2014;40:134–141.
  • Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727–733.
  • Harumi O, Goh CL. The effect of melasma on the quality of life in a sample of women living in Singapore. J Clini Aesthetic Dermatol. 2016;9:21–24.
  • Balkrishnan R, McMichael AJ, Camacho FT, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149:572–577.
  • Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237.
  • Kang HY, Hwang JS, Lee JY, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154:1094–1099.
  • Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698–710.
  • Inomata S, Matsunaga Y, Amano S, et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol. 2003;120:128–134.
  • Manuskiatti W, Pattanaprichakul P, Inthasotti S, et al. Thermal response of in vivo human skin to fractional radiofrequency microneedle device. BioMed Res Int. 2016;2016:1.
  • Kim JH, Kim H, Park HC, et al. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. J Invest Dermatol. 2010;130:2333–2335.
  • Chan NP, Ho SG, Shek SY, et al. A case series of facial depigmentation associated with low fluence Q-switched 1064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010;42:712–719.
  • Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36:76–87.
  • Kwon HH, Park HY, Choi SC, et al. Novel device-based acne treatments: comparison of a 1450-nm diode laser and microneedling radiofrequency on mild-to-moderate acne vulgaris and seborrhoea in Korean patients through a 20-week prospective, randomized, split-face study. J Eur Acad Dermatol Venereol. 2018;32:639–644.
  • Kwon HH, Park HY, Choi SC, et al. Combined fractional treatment of acne scars involving non-ablative 1550-nm erbium-glass laser and micro-needling radiofrequency: a 16-week prospective, randomized split-face study. Acta Derm Venerol. 2017;97:947–951.
  • Taheri A, Mansoori P, Sandoval LF, et al. Entrance and propagation pattern of high-frequency electrical currents in biological tissues as applied to fractional skin rejuvenation using penetrating electrodes. Skin Res Technol. 2014;20:270–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.